Choosing an antidiabetic drug class with proven cardiovascular and mortality benefits is now advocated in guidelines.3,4,63 SGLT2 inhibitors and GLP-1 RAs should be recommended as second-line treatment options after metformin, echoing recommendations by the ADA and the American College of Cardiology.3,63 The choice between SGLT2 inhibitors and GLP-1 RAs should be tailor-made according to patient characteristics
Getting your injection is quick and simple: A vitamin injection is fast, targeted, and budget-friendly
If you should link to a third-party Website or digital service from The New Hazlett Center for the Performing Arts, you are subject to its privacy practices and policies, not ours
TGA named BPC157, GHKCu, TB500, retatrutide, and CJC1295 as examples of unapproved peptides
Nausea is one of the most frequently reported side effects of GLP-1 agonist medications